| NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00023-5906-23 | 00023-5906 | Triptorelin Pamoate | Trelstar | Hormonal Therapy | GnRH Agonist | Mar 11, 2010 | In Use | ||||
| 71921-0190-33 | 71921-0190 | Exemestane | Exemestane | 25.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jan 15, 2021 | In Use | ||
| 55150-0311-05 | 55150-0311 | Hydroxyprogesterone Caproate | Hydroxyprogesterone Caproate | 1250.0 mg/5mL | Hormonal Therapy | Progestin | Intramuscular | May 9, 2019 | In Use | ||
| 51862-0447-05 | 51862-0447 | Tamoxifen Citrate | Tamoxifen Citrate | 10.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Aug 3, 2016 | Nov 30, 2019 | In Use | |
| 63629-5269-09 | 63629-5269 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jul 7, 2020 | In Use | ||
| 70518-1869-00 | 70518-1869 | letrozole | Letrozole | 2.5 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Feb 13, 2019 | Sep 23, 2019 | No Longer Used | |
| 00182-1864-00 | 00182-1864 | Megestrol Acetate | Megestrol Acetate | Hormonal Therapy | Progestin Analog | Oral | Jun 3, 2010 | Nov 30, 2010 | No Longer Used | ||
| 51862-0447-10 | 51862-0447 | Tamoxifen Citrate | Tamoxifen Citrate | 10.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Aug 3, 2016 | Jul 31, 2022 | In Use | |
| 00781-9164-75 | 00781-9164 | Octreotide Acetate | Octreotide Acetate | Hormonal Therapy | Somatostatin Analog | Oct 21, 1988 | Jun 29, 2014 | No Longer Used | |||
| 72603-0274-01 | 72603-0274 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Jul 10, 2024 | In Use | ||
| 00069-1307-10 | 00069-1307 | epoetin alfa-epbx | RETACRIT | 4000.0 [iU]/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Jun 18, 2018 | In Use | ||
| 54569-0812-05 | 54569-0812 | Estrogens, Conjugated | Premarin | 0.625 mg/1 | Hormonal Therapy | Estrogen | Oral | Jan 1, 2006 | In Use | ||
| 63187-0080-18 | 63187-0080 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Mar 25, 2022 | In Use | ||
| 68001-0522-85 | 68001-0522 | Fulvestrant | FULVESTRANT | 250.0 mg/5mL | Hormonal Therapy | Estrogen Receptor Antagonist | Intramuscular | Oct 29, 2021 | In Use | ||
| 63629-2614-05 | 63629-2614 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 5.0 mg/1 | Hormonal Therapy | Progestin | Oral | Jul 7, 2015 | In Use | ||
| 00310-7720-10 | 00310-7720 | Fulvestrant | Fulvestrant | 50.0 mg/mL | Hormonal Therapy | Estrogen Receptor Antagonist | Intramuscular | Oct 8, 2019 | Mar 31, 2023 | No Longer Used | |
| 55513-0010-04 | 55513-0010 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Oct 1, 2001 | Mar 31, 2009 | No Longer Used | |||
| 00555-0886-04 | 00555-0886 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 28, 1997 | In Use | ||
| 43063-0201-01 | 43063-0201 | Estradiol | Estradiol | 2.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Dec 10, 2009 | Oct 2, 2017 | No Longer Used | |
| 00078-0182-61 | 00078-0182 | Octreotide Acetate | Sandostatin | 500.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Aug 13, 2012 | In Use | ||
| 55513-0823-10 | 55513-0823 | Epoetin alfa | Epogen | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Mar 3, 1997 | Jul 31, 2010 | No Longer Used | |||
| 54868-4170-00 | 54868-4170 | Raloxifene Hydrochloride | Evista | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | May 11, 2000 | In Use | ||
| 55513-0097-91 | 55513-0097 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sep 25, 2006 | Feb 28, 2009 | No Longer Used | |||
| 54868-5428-00 | 54868-5428 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sep 13, 2006 | Jun 30, 2013 | No Longer Used | |||
| 67457-0239-01 | 67457-0239 | Octreotide Acetate | Octreotide Acetate | 50.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Apr 1, 2011 | In Use |
Found 11888 results — Export these results
Home